- Home
- / Liwanli
Liwanli
Stock Price
NT$21.4
2024-10-29
Market Capitalization
NT$1.7 B
2024-10-29
Revenue
NT$125.5 M
FY, 2025
Liwanli Summary
Company Summary
- Overview
- Liwanli is a research and development company in the field of biotechnology and medical care. It offers powder packs, drinks, drops, capsules, health tablets, enzyme powders, nutrient powders, and other products.
- Type
- Public
- Status
- Active
- Founded
- 1991
- Cybersecurity rating
Table of Contents
Liwanli Financials
Summary Financials
- Revenue (FY, 2025)
- NT$125.5M
- Gross profit (FY, 2025)
- NT$59.5M
- Net income (FY, 2025)
- NT$158.1M
- Cash (FY, 2025)
- NT$146.4M
- EBIT (FY, 2025)
- NT$148.0M
- Enterprise value
- $1.6B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026